Related Experiment Video
Updated: Feb 3, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Rhotekin 2 silencing inhibits proliferation and induces apoptosis in human osteosarcoma cells
Xiong Wang1, Lei Zhang2, Wenji Wang1
1Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou 730000, China.
Abstract:
Human osteosarcoma is the most frequent primary malignant of bone, and often occurs in adolescents. However, molecular mechanism of this disease remains unclear. In the present study, we found that the level of Rhotekin 2 (RTKN2) was up-regulated in osteosarcoma tissues and cell lines. In addition, silencing of RTKN2 of human osteosarcoma cell lines U2OS, inhibited proliferation, and induced G1 phase cell cycle arrest via reducing the level of the cyclin-dependent kinase 2 (CDK2). Furthermore, RTKN2 knockdown in the U2OS cells induced apoptosis by increasing the level of Bax and decreasing the level of Bcl2. These results suggested that RTKN2 is involved in the progression of human osteosarcoma, and may be a potential therapeutic target.
Insights
Rhotekin 2 (RTKN2) is elevated in osteosarcoma, a common bone cancer. Inhibiting RTKN2 in cancer cells reduced proliferation and induced cell death, suggesting RTKN2 as a potential therapeutic target for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Human osteosarcoma is the most common primary bone malignancy, frequently affecting adolescents.
- The underlying molecular mechanisms driving osteosarcoma development and progression are not fully understood.
Purpose of the Study:
- To investigate the role of Rhotekin 2 (RTKN2) in human osteosarcoma.
- To determine if RTKN2 could serve as a potential therapeutic target for osteosarcoma.
Main Methods:
- RTKN2 expression levels were analyzed in osteosarcoma tissues and cell lines.
- RTKN2 was silenced in human osteosarcoma U2OS cells to assess its functional impact.
- Cell proliferation, cell cycle progression (G1 phase arrest), apoptosis (Bax and Bcl2 levels), and cyclin-dependent kinase 2 (CDK2) levels were evaluated.
Main Results:
- RTKN2 expression was found to be upregulated in osteosarcoma tissues and cell lines.
- Silencing RTKN2 in U2OS cells inhibited cell proliferation.
- RTKN2 knockdown led to G1 phase cell cycle arrest by reducing CDK2 levels.
- Knockdown of RTKN2 induced apoptosis through increased Bax and decreased Bcl2 levels.
Conclusions:
- RTKN2 plays a significant role in the progression of human osteosarcoma.
- RTKN2 represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
Apoptosis
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Enzyme Inhibition
Induced Pluripotent Stem Cells

